National Center for Complementary and Alternative Medicine (NCCAM)

NIH…Turning Discovery Into Health®

Follow NCCAM: Subscribe to our email update Subscribe to the NCCAM RSS feed Follow NCCAM on TwitterRead our disclaimer about external links Follow NCCAM on FacebookRead our disclaimer about external links

Menu

NCCAM Explores New Opportunities for Future Collaboration with Industry


For Immediate Release:

Tuesday, April 17, 2001

Contact

Anita Greene
NCCAM Press Office, 301-496-1712

The National Center for Complementary and Alternative Medicine (NCCAM), a component of the NIH, will hold a colloquium on May 14, 2001, to explore opportunities to collaborate with two key groups:

  • Industrial stakeholders that produce, label, and market complementary and alternative medicine (CAM) therapeutics (e.g., dietary supplements and other biologically based treatments).
  • Organizations that develop and apply standards to determine the quality and safety of these products.

The purpose of the meeting is to begin a dialogue on how NCCAM and industry can work together to definitively evaluate CAM therapeutic products for composition, safety, and efficacy, and to obtain input from the broad stakeholder community.

What?

Senator Tom Harkin (D-IA), who spearheaded legislation to create NCCAM (formerly the Office of Alternative Medicine), will open the colloquium, Exploring Opportunities for Collaboration with Industry, with an overview of NCCAM’s legislative mandate. Stephen E. Straus, M.D., Director of NCCAM, will discuss NCCAM’s perspective with respect to opportunities to establish collaboration with industry. Myron S. Weinberg, Ph.D., Chairman of the Weinberg Group, will serve as chair for this colloquium.

Leaders from key Federal Government regulatory agencies, major industrial, non-profit, consumers, and researcher groups will address important topics:

  1. The role of NCCAM and the NIH Office of Dietary Supplements in studying CAM therapeutics within the context of the NIH mission.
  2. The scope of interests and needs of the CAM therapeutics industry in developing and marketing CAM therapeutics.
  3. Areas of interest common to NCCAM and the CAM therapeutics industry.
  4. Areas of complementary expertise contributed by NCCAM and the CAM therapeutics industry.
  5. Regulatory authorities and responsibilities of other Federal agencies. Ample opportunity will be provided for audience discussion of these issues.

Additional information, including an agenda and featured speakers at this meeting, is available at the NCCAM Web site.

Who Should Attend?

Individuals and representatives from the following organizations should attend this meeting:

  • CAM therapeutics suppliers of raw materials, manufacturers, and distributors
  • Members of organizations that develop and apply standards to determine quality and safety of CAM therapeutics
  • Consumers
  • Practitioners of conventional and complementary and alternative medicine, and members of the allied health professions
  • Researchers and research administrators
  • Policy makers
  • Publishers of compendia of information related to CAM therapeutics
  • Regulatory lawyers
  • Government regulators

When?

Monday, May 14, 2001

8:00 a.m.–5:45 p.m. EDT

Where?

The meeting will take place at the Washington Monarch Hotel located at

2401 M Street, NW.

Washington, D.C.

Register Now:

Registration is free for credentialed press only; however, space is limited. Please contact Anita Greene, NCCAM Press Officer, at 301-496-1712 as soon as possible to make a reservation.

NCCAM is dedicated to exploring complementary and alternative medical (CAM) practices in the context of rigorous science, training CAM researchers, and disseminating authoritative information.

For additional information, including fact sheets, press releases, and other information about NCCAM, please visit our Web site.